These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36160434)

  • 1. Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials.
    Wu Z; Han Z; Liu B; Shen N
    Front Pharmacol; 2022; 13():971890. PubMed ID: 36160434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
    Sisay M
    Front Pharmacol; 2020; 11():791. PubMed ID: 32574236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The journey of remdesivir: from Ebola to COVID-19.
    Pardo J; Shukla AM; Chamarthi G; Gupte A
    Drugs Context; 2020; 9():. PubMed ID: 32547625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.
    Williamson BN; Feldmann F; Schwarz B; Meade-White K; Porter DP; Schulz J; van Doremalen N; Leighton I; Yinda CK; Pérez-Pérez L; Okumura A; Lovaglio J; Hanley PW; Saturday G; Bosio CM; Anzick S; Barbian K; Cihlar T; Martens C; Scott DP; Munster VJ; de Wit E
    Nature; 2020 Sep; 585(7824):273-276. PubMed ID: 32516797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.
    Sun D
    AAPS J; 2020 May; 22(4):77. PubMed ID: 32458279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Mini Review on Discovery and Synthesis of Remdesivir as an Effective and Promising Drug against COVID-19.
    Zarenezhad E; Behrouz S; Farjam M; Rad MNS
    Russ J Bioorg Chem; 2021; 47(3):609-621. PubMed ID: 34149273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an updated systematic review and meta-analysis.
    Santenna C; Vidyasagar K; Amarneni KC; Ghanta SN; Sadasivam B; Pathan S; Padmavathi R
    Ther Adv Drug Saf; 2021; 12():20420986211042517. PubMed ID: 34594487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials.
    Gebrie D; Getnet D; Manyazewal T
    BMJ Open; 2020 Jun; 10(6):e039159. PubMed ID: 32503874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir and its antiviral activity against COVID-19: A systematic review.
    Frediansyah A; Nainu F; Dhama K; Mudatsir M; Harapan H
    Clin Epidemiol Glob Health; 2021; 9():123-127. PubMed ID: 32838064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review.
    Qomara WF; Primanissa DN; Amalia SH; Purwadi FV; Zakiyah N
    Int J Gen Med; 2021; 14():8557-8571. PubMed ID: 34849001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
    Antinori S; Cossu MV; Ridolfo AL; Rech R; Bonazzetti C; Pagani G; Gubertini G; Coen M; Magni C; Castelli A; Borghi B; Colombo R; Giorgi R; Angeli E; Mileto D; Milazzo L; Vimercati S; Pellicciotta M; Corbellino M; Torre A; Rusconi S; Oreni L; Gismondo MR; Giacomelli A; Meroni L; Rizzardini G; Galli M
    Pharmacol Res; 2020 Aug; 158():104899. PubMed ID: 32407959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality Benefit of Remdesivir in COVID-19: A Systematic Review and Meta-Analysis.
    Bansal V; Mahapure KS; Bhurwal A; Gupta I; Hassanain S; Makadia J; Madas N; Armaly P; Singh R; Mehra I; O'Horo JC; Kashyap R
    Front Med (Lausanne); 2020; 7():606429. PubMed ID: 33585508
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness.
    Aleem A; Mahadevaiah G; Shariff N; Kothadia JP
    Proc (Bayl Univ Med Cent); 2021 Mar; 34(4):473-477. PubMed ID: 34219928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis.
    Meo SA; Zaidi SZA; Shang T; Zhang JY; Al-Khlaiwi T; Bukhari IA; Akram J; Klonoff DC
    J King Saud Univ Sci; 2020 Oct; 32(7):3159-3166. PubMed ID: 32921965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report study of the first five COVID-19 patients treated with remdesivir in France.
    Dubert M; Visseaux B; Isernia V; Bouadma L; Deconinck L; Patrier J; Wicky PH; Le Pluart D; Kramer L; Rioux C; Le Hingrat Q; Houhou-Fidouh N; Yazdanpanah Y; Ghosn J; Lescure FX
    Int J Infect Dis; 2020 Sep; 98():290-293. PubMed ID: 32619764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review.
    Rezapour A; Behroozi Z; Nasirzadeh M; Rezaeian M; Barzegar M; Tashakori-Miyanroudi M; Sayyad A; Souresrafil A
    Infect Dis Poverty; 2023 Apr; 12(1):39. PubMed ID: 37081575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020.
    Nabil A; Uto K; Elshemy MM; Soliman R; Hassan AA; Ebara M; Shiha G
    EXCLI J; 2020; 19():992-1016. PubMed ID: 32788913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance.
    Yan D; Ra OH; Yan B
    Anim Dis; 2021; 1(1):15. PubMed ID: 34778881
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.